Aragvadhadi Kwath: Benefits, Evidence & Safety

TL;DR

Aragvadhadi kwath is a classical Ayurvedic decoction built around aragvadha (Cassia fistula), with a long co-ingredient list that varies between sources. No human trial of the kwath itself was found. The closest evidence is a 45-patient randomized study of a related ghanvati tablet plus topical oil, where psoriasis PASI scores fell 29.25%.

What it is

Aragvadhadi Kwath is a classical Ayurvedic herbal decoction, a kwath or kashayam, belonging to the Aragvadhadi group associated with Ashtanga Hridaya (Sutrasthana 15:17–18) (Ayurvedic formulary mirror). Its chief ingredient is aragvadha (Cassia fistula), combined with a long list of co-ingredients that commonly includes kutaja/indrayava, patala, nimba, guduchi, patha, bhunimba, sahachara, patola, karanja, chirabilva, chitraka, bitter gourd, and madanaphala (formulary mirror).

Here's the part I want to nail down early, because it governs everything else on this page: ingredient lists and botanical mappings differ between sources. There is no single universal recipe. Whatever is on the product label is the formula you're actually discussing, not the classical list above. Verify the label.

Traditional use

In formulary tradition, Aragvadhadi preparations appear among the classical kashayam (decoction) compilations built around the Aragvadhadi group of herbs (formulary mirror). That is a statement about formulary tradition. It is not evidence of efficacy. I am saying this explicitly because for formulas like this one, the tradition section is often the whole marketing case, and here it has to stand alone: the human research comes next, and it is about a different preparation.

What modern research says

The closest thing to evidence is a 2024 single-blind randomized study from Gupta et al. in the Journal of Ayurveda and Integrated Medical Sciences. Forty-five psoriasis patients, three groups of 15. The relevant group received Aragvadhadi Gana ghanvati, two 500 mg tablets twice daily for 45 days, together with topical Karanjadi Taila. PASI scores fell 29.25% within that group. But between-group differences were often not statistically significant (study, DOI: 10.21760/jaims.9.4.1).

A within-group drop that doesn't cleanly beat the other arms. I would call that a hint, not a result.

Why this is only indirect evidence

Here is the gap, and it is the whole story of this article. The study tested a concentrated tablet plus a topical oil. Not Aragvadhadi Kwath. Not the water decoction. Not alone. So whatever it found cannot be transferred to the kwath, full stop. A separate 2025 study combined a related kashayam with herbal bathing in 10 patients, which is the same problem in different clothes: a combination intervention, not evidence for the kwath alone (JAIMS 2025). No human trial of Aragvadhadi Kwath by itself was found. Anyone citing the psoriasis numbers for the decoction is misreading the study.

Safety & contraindications

No published safety studies of Aragvadhadi Kwath itself were found. I want to be blunt about what that means: this is a complex multi-herb formula, its exact composition varies between manufacturers, and it includes pharmacologically active ingredients, so interactions and side effects cannot be ruled out. Safety in pregnancy, breastfeeding, and children is unestablished. The psoriasis study's ghanvati-plus-oil results cannot vouch for the kwath's safety, any more than the tablet's efficacy can. Anyone considering it should consult a qualified practitioner and verify the product's actual ingredient list.

FAQs

What is aragvadhadi kwath?

Aragvadhadi Kwath is a classical Ayurvedic herbal decoction, a kwath or kashayam, built around aragvadha (Cassia fistula), associated with the Aragvadhadi group of Ashtanga Hridaya. It is a multi-herb formula: published ingredient lists name many co-ingredients, but the exact composition varies between sources and manufacturers. Check the label, not the tradition.

What ingredients does it contain?

Commonly reported ingredients include aragvadha, kutaja (indrayava), patala, nimba, guduchi, patha, bhunimba, sahachara, patola, karanja, chirabilva, chitraka, bitter gourd, and madanaphala. But lists differ, and I mean that seriously. Because there is no single universal recipe in the sources found, always verify the actual ingredient list on the product label.

Does it help psoriasis?

The closest evidence is a 2024 randomized study in which 45 psoriasis patients received a related concentrated tablet (Aragvadhadi Gana ghanvati) plus a topical oil. PASI scores fell 29.25% within that group, though between-group differences were often nonsignificant. This tested the tablet-plus-oil combination, not the kwath decoction alone, so it does not prove the kwath helps psoriasis. Close is not the same.

Can I use the study's tablet dose for the kwath?

No. The study used two 500 mg ghanvati tablets twice daily, a concentrated tablet form taken with a topical oil, which is a different preparation from a water decoction (kwath). Tablet doses do not transfer to decoctions, and no official dosage for the kwath itself was found. Dosing should come from a qualified practitioner, not from the study.

Is aragvadhadi kwath safe?

No published safety studies of the kwath itself were found. Its multi-herb composition varies between products and includes pharmacologically active ingredients, so interactions and side effects cannot be ruled out. Safety in pregnancy, breastfeeding, and children is unestablished. Consult a qualified practitioner before use, especially if you take other medicines.

What is the difference between a kwath and a ghanvati?

A kwath (kashayam) is a water decoction: herbs boiled in water, the liquid strained for use. A ghanvati is a concentrated tablet made by further boiling down a decoction into a solid extract and compressing it into pills. They differ in concentration, shelf life, and dosing, so evidence for one form does not automatically apply to the other. This distinction is doing a lot of work on this page.

Sources

Tier 2 — Peer-reviewed research

The psoriasis study is Gupta et al.'s single-blind randomized study of Aragvadhadi Gana ghanvati (two 500 mg tablets twice daily, 45 days) with topical Karanjadi Taila in 45 psoriasis patients (15 per group), with a within-group PASI reduction of 29.25%, published in the Journal of Ayurveda and Integrated Medical Sciences in 2024 (DOI: 10.21760/jaims.9.4.1; study PDF). The second item is the 2025 combination study of a related kashayam (Aaragwadh Amritadi Kashayam) with Khadir herbal bathing in 10 patients: a combination intervention, not evidence for Aragvadhadi Kwath alone, published in JAIMS (article).

Tier 3 — Secondary and traditional references

The classical association and ingredient lists come from the Asoka Ayurveda formulary mirror: the classical kashayam listings including the Aragvadhadi group (asokaayurveda.com). This is a secondary traditional reference, used here for formulary identity only, not for any efficacy claim.

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use, especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.